EUVIMEDEUVIMED entdecken
Crossref

Development of N -(4-(1 H -Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability

Michela Puxeddu iD, Lele Ling, Silvia Ripa, Michele D'Ambrosio, Marianna Nalli, Anastasia Parisi, Pietro Sciò, Antonio Coluccia iD, Arianna Granese, Martina Santelli, Domiziana Masci iD, Petra Cuřínová iD und 11 weitere

Journal of Medicinal Chemistry · 28.11.2024 · 67 (22) · 20298-20314

DOI: 10.1021/acs.jmedchem.4c01708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 07.11.2024. Verfasst von Michela Puxeddu und 22 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of R…. Hauptthemen laut MEDLINE: Antineoplastic Agents, beta Catenin, Sulfonamides, Cell Proliferation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Ministero dell?Istruzione, dell?Universit? e della Ricerca, Sapienza Universit? di Roma, Associazione Italiana per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The potential as a cancer therapeutic target of the recently reported hotspot binding region close to Lys508 of the β-catenin armadillo repeat domain was not exhaustively explored. In order to get more insight, we synthesized novel N-(heterocyclylphenyl)benzenesulfonamides 6-28. The new compounds significantly inhibited Wnt-dependent transcription as well as SW480 and HCT116 cancer cell proliferation. Compound 25 showed binding mode consistent with this hotspot binding region. Compound 25 inhibited the growth of SW480 and HCT116 cancer cells with IC50's of 2 and 0.12 μM, respectively, and was superior to the reference compounds 5 and 5-FU. 25 inhibited the growth of HCT-116 xenografted in BALB/Cnu/nu mice, reduced the expression of the proliferation marker Ki67, and significantly affected the expression of cancer-related genes. After incubation with human and mouse liver microsomes, 25 showed a higher metabolic stability than 5. Compound 25 aims to be a promising lead for the development of colorectal cancer anticancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agentsbeta CateninSulfonamidesCell ProliferationMice, Inbred BALB CHumansAnimalsMiceStructure-Activity RelationshipCell Line, TumorMice, NudeXenograft Model Antitumor AssaysMicrosomes, LiverHCT116 Cells

Substanzen

Antineoplastic Agentsbeta CateninSulfonamides

Autor:innen und Institutionen

  • Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
  • Department of Acupuncture and Moxibustion, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, 200086 Shanghai, China.
  • Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Rome, Italy.
  • Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy.
  • Department of Organic Chemistry, University of Chemistry and Technology Prague, Technická 5, 16628 Prague 6, Czech Republic.
  • GSTeP-Organoids Research Core Facility, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.

ORCID-Profile: Michela Puxeddu, Antonio Coluccia, Domiziana Masci, Petra Cuřínová, Mariano Stornaiuolo, Giulio Dondio, Romano Silvestri, Giuseppe La Regina

Förderung

  • Ministero dell?Istruzione, dell?Universit? e della Ricerca
  • Sapienza Universit? di Roma
  • Associazione Italiana per la Ricerca sul Cancro
  • China Academy of Traditional Chinese Medicine
  • Ministero della Salute
  • Ministero dell'Universit? e della Ricerca
  • Universit? Cattolica del Sacro Cuore
  • Fondazione Umberto Veronesi

Zitieren

APA

Puxeddu, M., Ling, L., Ripa, S., D'Ambrosio, M., Nalli, M., Parisi, A., Sciò, P., Coluccia, A., Granese, A., Santelli, M., Masci, D., Cuřínová, P., Naro, C., Sette, C., Pastore, A., Stornaiuolo, M., Bigogno, C., Dondio, G., Di Magno, L., …, & La Regina, G. (2024). Development of N -(4-(1 H -Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability. Journal of Medicinal Chemistry, 67(22), 20298-20314. https://doi.org/10.1021/acs.jmedchem.4c01708

Vancouver

Puxeddu M, Ling L, Ripa S, D'Ambrosio M, Nalli M, Parisi A, et al. Development of N -(4-(1 H -Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability. Journal of Medicinal Chemistry. 2024;67(22):20298-20314. doi:10.1021/acs.jmedchem.4c01708

BibTeX
@article{Puxeddu2024,
  author = {Puxeddu, Michela and Ling, Lele and Ripa, Silvia and D'Ambrosio, Michele and Nalli, Marianna and Parisi, Anastasia and Sciò, Pietro and Coluccia, Antonio and Granese, Arianna and Santelli, Martina and Masci, Domiziana and Cuřínová, Petra and Naro, Chiara and Sette, Claudio and Pastore, Arianna and Stornaiuolo, Mariano and Bigogno, Chiara and Dondio, Giulio and Di Magno, Laura and Canettieri, Gianluca and Liu, Te and Silvestri, Romano and La Regina, Giuseppe},
  title = {Development of N -(4-(1 H -Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {22},
  pages = {20298--20314},
  doi = {10.1021/acs.jmedchem.4c01708}
}
Kostenlos starten →